Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 787

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 787
---
 statements. We believe that our audits provide a reasonable basis for our opinion. /s/ PricewaterhouseCoopers AG
Zurich, Switzerland May 15, 2024
We have served as the Company’s auditor since 2021. Annex F-117

NLS PHARMACEUTICS LTD.
BALANCE SHEETS

| ASSETS                                                                                                                                                     
 Current assets:                                                                                                                                            |     | December 31, 
 2023         |             |   |     | 2022 |             |   |
|:-----------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-------------|------------:|:--|:----|:-----|------------:|:--|
| Cash and cash equivalents                                                                                                                                  |     | $            |     897,680 |   |     | $    |   8,948,400 |   |
| Prepaid expenses and other current assets (Note 3)                                                                                                         |     |              |     925,382 |   |     |      |     297,998 |   |
| Total current assets                                                                                                                                       |     |              |   1,823,062 |   |     |      |   9,246,398 |   |
| Property and equipment (Note 4)                                                                                                                            |     |              |       6,694 |   |     |      |      18,102 |   |
| Other assets                                                                                                                                               |     |              |      16,885 |   |     |      |      12,143 |   |
| Total assets                                                                                                                                               |     | $            |   1,846,641 |   |     | $    |   9,276,643 |   |
| LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                                                                       |     |              |             |   |     |      |             |   |
| Current liabilities:                                                                                                                                       |     |              |             |   |     |      |             |   |
| Accounts payable, including related party of $265,864 and $53,365, as of December 31, 2023 and 2022, respectively                                          |     | $            |   4,633,534 |   |     | $    |   2,373,276 |   |
| Related party short-term loan of $1,633,746 and $0, as of December 31, 2023 and 2022, respectively (Note 5)                                                |     |